It describes a commercial and scientific strategy: take an existing biologic molecule, engineer a meaningful clinical improvement, and submit it as a new molecular entity through a full Biologics License Application (BLA), not the abbreviated 351(k) biosimilar pathway
But what happened yesterday is another biopharma company that is developing a HUMIRA biosimilar Coherus decided to sell its biosimilars directly through cost plus pharmacy at 85% discount
Peptides such as adropin regulate glucose and increase insulin sensitivity
RB, MS, SD, ZS, KJ, and RD: data curation
"Moisture Protection Strategies in Pharmaceutical Packaging: Best Practices for Peptide Stability." Pharmaceutical Packaging Technology, 15(1), 89-107
The overall concentration of QD and thus glutathione (bound on the surface of QD) are in large excess compared to that of the H 2 O 2 ;hence the reaction can be regarded as a pseudo first-order reaction with respect to H 2 O 2